The Orlando Firm has represented thousands of consumers injured by the use of such pharmaceutical products as Fen-Phen, Rezulin, Propulsid, Phenylpropanolamine (PPA),Vioxx, Oxycotin, Accutane, Baycol and the depression drug Serzone.
One cannot watch the evening news without being bombarded with commercials for new pharmaceutical products. With the development and influx of so many new medications in the marketplace, we have discovered that many of these drugs unfortunately have devastating side effects and, in some persons, can cause more harm than they do good. Infants and small children died from taking Propulsid (cisapride), a drug designed to treat reflux in adults, but marketed and given to children in order to increase drug-manufacturer’s corporate profits. Users of Rezulin, a drug designed to treat Type II diabetes caused many users to suffer liver failure. Similar problems have been linked to Serzone, an anti-depressant medication, and users of Baycol, a commonly-prescribed cholesterol medication have suffered from a muscle-wasting condition known as rhabdomyolysis which has resulted in kidney failure and even death. People have actually died from taking diet drugs such as Fen-Phen. Still others have died or suffered debilitating hemorrhagic strokes from ingesting Phenylpropanolamine (PPA), an ingredient previously found in many prescription and over-the-counter diet, cough and cold remedies. Certainly, no one would risk such serious injury or death simply to shed a few pounds or combat the symptoms of a common cold or cough. These represent but a handful of what we deem to be potentially dangerous drugs which have been marketed and sold to consumers as “wonder drugs,” as multi-billion dollar pharmaceutical companies push to amass even greater fortunes at the expense -- and in some instances, the life -- of the individual.
Over the past several years, we have become recognized as a national leader in the pursuit of legal claims against the powerful pharmaceutical industry. The Orlando Firm, P.C. has represented countless consumers who have suffered serious bodily injuries as a result of the use of defective drugs, or resulting from a manufacturer’s failure to warn consumers of the oftentimes devastating side effects associated with the use of some drugs. The firm has been retained to represent clients in over a dozen states, concentrated in and around the Southeast, and has filed lawsuits on behalf of its clients in both state and federal courts around the country.
On the national level, The Orlando Firm, P.C., provides case development and trial support to various litigation consortiums to bring pharmaceutical manufacturers to task for injuries which result from negligent manufacture or labeling of their products. The firm is involved in both class action and multi-district litigation (MDL) consortiums nationally and, in fact, Mr. Orlando has been appointed to leadership positions on several national committees in the areas of state-federal coordination, liaison committees, science and expert witness development, technological development and in litigation-support roles.
As The Orlando Firm, P.C. continues to grow, both in representative size and premiere reputation, we expect our national prominence in the defense of injured consumers to increase. We will do our best to make sure that you make the recovery to which you are entitled. And always remember, if we don’t win your case, you pay us nothing1.
NOTE: You are not a client of The Orlando Firm, P.C., until you have executed an attorney-client contract for employment of the firm, and the contract has been signed by a member of the firm.
1 Mass tort/Pharmaceutical Liability cases are handled on a contingency fee basis unless otherwise agreed upon by the client and the firm. Other types of cases may be governed by fee agreements other than contingency fees.